They found that the level of Kcr is downregulated in hemodialysis patients but increased in CKD patients, suggesting an important regulatory role for Kcr and a dynamic change in its levels in the development of AKI and during the AKI-to-CKD transition. Here, CLEC4F is linked to chronic kidney disease.